116 related articles for article (PubMed ID: 36828102)
1. The effect of mitochondria-targeted slow hydrogen sulfide releasing donor AP39-treatment on airway inflammation.
Karaman Y; Kaya-Yasar Y; Eylem CC; Onder SC; Nemutlu E; Bozkurt TE; Sahin-Erdemli I
Eur J Pharmacol; 2023 May; 946():175619. PubMed ID: 36828102
[TBL] [Abstract][Full Text] [Related]
2. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice.
Karaman Y; Kaya-Yasar Y; Bozkurt TE; Sahin-Erdemli I
Basic Clin Pharmacol Toxicol; 2021 May; 128(5):652-660. PubMed ID: 33369105
[TBL] [Abstract][Full Text] [Related]
4. Both the H
Ahmad A; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):348-355. PubMed ID: 27639598
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of hydrogen sulfide on ozone-induced airway inflammation, oxidative stress, and bronchial hyperresponsiveness.
Zhang P; Li F; Wiegman CH; Zhang M; Hong Y; Gong J; Chang Y; Zhang JJ; Adcock I; Chung KF; Zhou X
Am J Respir Cell Mol Biol; 2015 Jan; 52(1):129-37. PubMed ID: 25010831
[TBL] [Abstract][Full Text] [Related]
6. AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo.
Ahmad A; Olah G; Szczesny B; Wood ME; Whiteman M; Szabo C
Shock; 2016 Jan; 45(1):88-97. PubMed ID: 26513708
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice.
Ikeda K; Marutani E; Hirai S; Wood ME; Whiteman M; Ichinose F
Nitric Oxide; 2015 Sep; 49():90-6. PubMed ID: 25960429
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury.
Magierowska K; Korbut E; Wójcik-Grzybek D; Bakalarz D; Sliwowski Z; Cieszkowski J; Szetela M; Torregrossa R; Whiteman M; Magierowski M
J Control Release; 2022 Aug; 348():321-334. PubMed ID: 35654168
[TBL] [Abstract][Full Text] [Related]
9. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.
Szczesny B; Módis K; Yanagi K; Coletta C; Le Trionnaire S; Perry A; Wood ME; Whiteman M; Szabo C
Nitric Oxide; 2014 Sep; 41():120-30. PubMed ID: 24755204
[TBL] [Abstract][Full Text] [Related]
10. The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H
Pomierny B; Krzyżanowska W; Jurczyk J; Skórkowska A; Strach B; Szafarz M; Przejczowska-Pomierny K; Torregrossa R; Whiteman M; Marcinkowska M; Pera J; Budziszewska B
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360581
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of VGX-1027 in PM
Xu M; Li F; Wang M; Zhang H; Xu L; Adcock IM; Chung KF; Zhang Y
Eur J Pharmacol; 2019 Jan; 842():373-383. PubMed ID: 30419239
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection by H2S Donors: Nitric Oxide-Dependent and ‑Independent Mechanisms.
Chatzianastasiou A; Bibli SI; Andreadou I; Efentakis P; Kaludercic N; Wood ME; Whiteman M; Di Lisa F; Daiber A; Manolopoulos VG; Szabó C; Papapetropoulos A
J Pharmacol Exp Ther; 2016 Sep; 358(3):431-40. PubMed ID: 27342567
[TBL] [Abstract][Full Text] [Related]
13. The mitochondria-targeted sulfide delivery molecule attenuates drugs-induced gastropathy. Involvement of heme oxygenase pathway.
Magierowska K; Wójcik-Grzybek D; Korbut E; Bakalarz D; Ginter G; Danielak A; Kwiecień S; Chmura A; Torregrossa R; Whiteman M; Magierowski M
Redox Biol; 2023 Oct; 66():102847. PubMed ID: 37597422
[TBL] [Abstract][Full Text] [Related]
14. A novel slow-releasing hydrogen sulfide donor, FW1256, exerts anti-inflammatory effects in mouse macrophages and in vivo.
Huang CW; Feng W; Peh MT; Peh K; Dymock BW; Moore PK
Pharmacol Res; 2016 Nov; 113(Pt A):533-546. PubMed ID: 27687956
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory role of hydrogen sulfide in airway hyperresponsiveness and inflammation in a mouse model of asthma.
Zhang G; Wang P; Yang G; Cao Q; Wang R
Am J Pathol; 2013 Apr; 182(4):1188-95. PubMed ID: 23395089
[TBL] [Abstract][Full Text] [Related]
16. Role of tachykinins in sephadex-induced airway hyperreactivity and inflammation in guinea pigs.
Tramontana M; Santicioli P; Giuliani S; Catalioto RM; Lecci A; Carini F; Maggi CA
Eur J Pharmacol; 2002 Mar; 439(1-3):149-58. PubMed ID: 11937105
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Sephadex-induced lung inflammation and bronchial hyperreactivity by rapamycin.
Francischi JN; Conroy DM; Cloutier S; Sirois P
Braz J Med Biol Res; 1993 Oct; 26(10):1105-10. PubMed ID: 7508777
[TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of poly(I:C) and LPS in BALB/c mice induces airway hyperresponsiveness and inflammation via different pathways.
Starkhammar M; Kumlien Georén S; Swedin L; Dahlén SE; Adner M; Cardell LO
PLoS One; 2012; 7(2):e32110. PubMed ID: 22355412
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness.
Taube C; Nick JA; Siegmund B; Duez C; Takeda K; Rha YH; Park JW; Joetham A; Poch K; Dakhama A; Dinarello CA; Gelfand EW
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):837-43. PubMed ID: 14742296
[TBL] [Abstract][Full Text] [Related]
20. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
